ACT-Midwest G1 — Abilene, Texas

ACT-Midwest G1 is a clinical research site located in Abilene, Texas, United States 79606.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

ACT-Midwest G1 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ulcerative Colitis.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ACT-Midwest G1?

ACT-Midwest G1 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ACT-Midwest G1 conducted?

ACT-Midwest G1 has 1 clinical trials on record, with 1 currently active. Their work covers Ulcerative Colitis.

Is ACT-Midwest G1 accredited by Crixeo Health?

ACT-Midwest G1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ACT-Midwest G1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.